Literature DB >> 28976545

A novel, smaller scaffold for Affitins: Showcase with binders specific for EpCAM.

Valentina Kalichuk1,2, Axelle Renodon-Cornière1, Ghislaine Béhar1, Federico Carrión3, Gonzalo Obal3, Mike Maillasson1,4, Barbara Mouratou1, Véronique Préat2, Frédéric Pecorari1.   

Abstract

Affitins are highly stable engineered affinity proteins, originally derived from Sac7d and Sso7d, two 7 kDa DNA-binding polypeptides from Sulfolobus genera. Their efficiency as reagents for intracellular targeting, enzyme inhibition, affinity purification, immunolocalization, and various other applications has been demonstrated. Recently, we have characterized the 7 kDa DNA-binding family, and Aho7c originating from Acidianus hospitalis was shown to be its smallest member with thermostability comparable to those of Sac7d and Sso7d. Here, after four rounds of selection by ribosome display against the human recombinant Epithelial Cell Adhesion Molecule (hrEpCAM), we obtained novel Aho7c-based Affitins. The binders were expressed in soluble form in Escherichia coli, displayed high stability (up to 74°C; pH 0-12) and were shown to be specific for the hrEpCAM extracellular domain with picomolar affinities (KD  = 110 pM). Thus, we propose Aho7c as a good candidate for the creation of Affitins with a 10% smaller size than the Sac7d-based ones (60 vs. 66 amino acids).
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Affitin; Aho7c; EpCAM protein engineering; Sac7d; ribosome display

Mesh:

Substances:

Year:  2017        PMID: 28976545     DOI: 10.1002/bit.26463

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  4 in total

Review 1.  Toxin Neutralization Using Alternative Binding Proteins.

Authors:  Timothy Patrick Jenkins; Thomas Fryer; Rasmus Ibsen Dehli; Jonas Arnold Jürgensen; Albert Fuglsang-Madsen; Sofie Føns; Andreas Hougaard Laustsen
Journal:  Toxins (Basel)       Date:  2019-01-17       Impact factor: 4.546

2.  Dual Functionalized Lactococcus lactis Shows Tumor Antigen Targeting and Cytokine Binding in Vitro.

Authors:  Abida Zahirović; Tina Vida Plavec; Aleš Berlec
Journal:  Front Bioeng Biotechnol       Date:  2022-01-26

3.  Model Affitin and PEG modifications onto siRNA lipid nanocapsules: cell uptake and in vivo biodistribution improvements.

Authors:  Pauline Resnier; Elise Lepeltier; Anthea Lucrezia Emina; Natacha Galopin; Jérôme Bejaud; Stephanie David; Caroline Ballet; Thierry Benvegnu; Frédéric Pecorari; Igor Chourpa; Jean-Pierre Benoit; Catherine Passirani
Journal:  RSC Adv       Date:  2019-08-30       Impact factor: 4.036

4.  Introduction of Modified BglBrick System in Lactococcus lactis for Straightforward Assembly of Multiple Gene Cassettes.

Authors:  Tina Vida Plavec; Tim Ključevšek; Aleš Berlec
Journal:  Front Bioeng Biotechnol       Date:  2021-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.